Annals of hepatology (1117 documentos)


61.-
62.-
Management Strategies for Liver Fibrosis
Altamirano Barrera, Alejandra1; Barranco Fragoso, Beatriz2; Méndez Sánchez, Nahum1
1Fundación Clínica Médica Sur, Unidad de Investigación de Hígado, Ciudad de México. México; 2Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado, Centro Médico Nacional 20 de Noviembre, Ciudad de México. México
[Annals of hepatology, México, 2017 Vol. 16 Núm. 1 Ene-Feb, Pág. 48-56]

   
63.-
64.-
   
65.-
66.-
67.-
Right Hepatic Lobe Resection and Thrombocytopenia
Adike, Abimbola1; Rakela, Jorge1; Czaplicki, Christopher2; Moss, Adyr3; Carey, Elizabeth1
1Mayo Clinic, Division of Gastroenterology and Hepatology, Phoenix, Arizona. Estados Unidos de América; 2Mayo Clinic, Department of Transplant Surgery, Phoenix, Arizona. Estados Unidos de América; 3Mayo Clinic, Department of Radiology, Phoenix, Arizona. Estados Unidos de América
[Annals of hepatology, México, 2017 Vol. 16 Núm. 1 Ene-Feb, Pág. 10-11]

   
68.-
69.-
70.-
Utility and safety of Tolvaptan in cirrhotic patients with hyponatremia: a prospective cohort study
Ji-Dong Jia1; Wen Xie1; Hui-Guo Ding1; Hua Mao2; Hui Guo3; Yonggang Li4; Xiaojin Wang5; Jie-Fei Wang6; Wei Lu7; Cheng-Zhong Li8; Yimin Mao9; Gui-Qiang Wang10; Yue-qiu Gao11; Bangmao Wang12; Qin Zhang9; Yan Ge13; Vincent Wai-Sun Wong14
1Capital Medical University, Beijing. China; 2Southern Medical University, Guangzhou, Guangdong. China; 3Tianjin University of Traditional Chinese Medicine, First Teaching Hospital, Tianjin. China; 4302 Military Hospital of People’s Liberation Army, Department of Integrative Medical Center, Beijing. China; 5Hospital 85 People’s Liberation Army of China, Shanghai. China; 6Fudan University, Shanghai Public Health Clinical Center, Shanghai. China; 7Tianjin Second People-s Hospital, Tianjin. China; 8The Second Military Medical University, Shanghai Hospital, Shanghai. China; 9Jiaotong University, School of Medicine, Shanghai. China; 10Peking University, First Hospital, Beijing. China; 11Shanghai University of Traditional Chinese Medicine, Shuguang Hospital, Shanghai. China; 12Tianjin Medical University General Hospital, Department of Gastroenterology, Tianjin. China; 13Guangdong Second Traditional Chinese Medicine Hospital, Guangzhou, Guangdong. China; 14The Chinese University of Hong Kong, Department of Medicine and Therapeutics, Hong Kong. China
[Annals of hepatology, México, 2017 Vol. 16 Núm. 1 Ene-Feb, Pág. 123-132]

71.-
72.-
73.-
Daclatasvir and Peginterferon/Ribavirin for Black/African-American and Latino Patients with HCV infection
Rodriguez Torres, Maribel; Lawitz, Eric1; Yangco, Bienvenido2; Jeffers, Lennox3; Han, Steven-Huy4; Thuluvath, Paul J5; Rustgi, Vinod6; Harrison, Stephen7; Ghalib, Reem8; Vierling, John M9; Luketic, Velimir10; Zamor, Philippe J11; Ravendhran, Natarajan12; Morgan, Timothy R13; Pearlman, Brian14; O'Brien, Christopher15; Khallafi, Hicham16; Pyrsopoulos, Nikolaos17; Kong, George18; McPhee, Fiona18; Yin, Philip D18; Hughes, Eric19; Treitel, Michelle19
1University of Texas, Health Science Center, San Antonio, Texas. Estados Unidos de América; 2Infectious Disease Research Institute, Tampa, Florida. Estados Unidos de América; 3Miami VA Medical Center, Miami, Florida. Estados Unidos de América; 4Pfleger Liver Institute, Los Angeles, California. Estados Unidos de América; 5Mercy Medical Center, Baltimore, Maryland. Estados Unidos de América; 6University of Pittsburgh, Medical Center, Pittsburgh, Pensilvania. Estados Unidos de América; 7Brooke Army Medical Center, San Antonio, Texas. Estados Unidos de América; 8North Texas Research Institute, Arlington, Texas. Estados Unidos de América; 9Baylor College of Medicine, Houston, Texas. Estados Unidos de América; 10Virginia Commonwealth University, School of Medicine, Richmond, Virginia. Estados Unidos de América; 11Carolinas Medical Center, Charlotte, Carolina del Norte. Estados Unidos de América; 12Digestive Disease Associates, Catonsville, Maryland. Estados Unidos de América; 13VA Long Beach Healthcare System, Long Beach, California. Estados Unidos de América; 14Atlanta Medical Center, Atlanta, Georgia. Estados Unidos de América; 15University of Miami, Schiff Center for Liver Diseases, Miami, Florida. Estados Unidos de América; 16Florida Hospital Transplant Center, Orlando, Florida. Estados Unidos de América; 17Rutgers-New Jersey Medical School, Newark, New Jersey. Estados Unidos de América; 18Bristol-Myers Squibb, Research and Development, Wallingford, Connecticut. Estados Unidos de América; 19Bristol-Myers Squibb, Research and Development, Princeton, New Jersey. Estados Unidos de América; 20Estados Unidos de América
[Annals of hepatology, México, 2016 Vol. 15 Núm. 6 Nov-Dic, Pág. 834-845]

   
74.-
75.-
76.-
77.-
78.-
79.-
MicroRNA-146b regulates hepatic stellate cell activation via targeting of KLF4
Ge, Shanfei1; Zhang, Lunli1; Xie, Jianping2; Liu, Fei2; He, Jinni3; He, Jinwen3; Wang, Xiaowei; Xiang, Tianxing1
1Nanchang University, The First Affiliated Hospital, Nanchang, Jiangxi. China; 2Central South University, Xiangya Hospital, Changsha, Hunan. China; 3Central South University, Xiangya School of Medicine, Changsha, Hunan. China
[Annals of hepatology, México, 2016 Vol. 15 Núm. 6 Nov-Dic, Pág. 918-928]

   
80.-